China News Agency, Beijing, July 15 (Li Jingze, Zhang Weiran) The Chinese Academy of Medical Sciences and the Social Sciences Literature Publishing House jointly issued the "Blue Book on Medical Reform: China's Medical Reform Development Report (2020)" (hereinafter referred to as the "Report"). The report reviews ten years of experience in the new round of medical and health system reform, highlights the 2019 medical improvement exhibition, and puts forward reform proposals for 2020 and the "Fourteenth Five-Year Plan".
Data map: A community hospital in Beijing placed the key content of the medical reform and the price comparison table of drugs in a prominent position in the registration hall. China News Service reporter Du Yanshe
Liang Wannian, director of the System Reform Department of the National Health and Health Commission of China, said in the report that 2019 is the 10th anniversary of the launch of a new round of medical reform. The implementation of various key tasks is good, and the indicators are generally better than 2018. The main indicators are presented Out of the "two advantages and one drop", that is, the allocation of health resources and the health status of residents are constantly optimizing, and the burden of people's medical treatment continues to decline.
Hierarchical diagnosis and treatment system improves service coverage
The report pointed out that promoting the construction of the medical consortium, developing family doctor contracting services and telemedicine are the three starting points for advancing graded diagnosis and treatment.
As a system innovation, the medical consortium adjusts and optimizes the structure of medical resources through various forms of organization, and magnifies the effect of advantageous medical resources. According to reports, China has identified 118 pilot cities for the construction of medical consortiums and 567 pilot counties for close county medical communities. Zhejiang, Shanxi, Anhui and other provinces unified the promotion of a close county medical community.
At the same time, family doctor contracting services gradually expand the coverage of contracting services. By the end of 2018, there were a total of 382,000 family doctors who signed up for services across the country. Family doctors from key populations signed 320 million people, with a coverage rate of 71.3%.
Telemedicine services are also helping graded diagnosis and treatment. As of the end of 2018, there were 1,452 third-level public hospitals and 2,746 second-level public hospitals that carried out telemedicine services in China, an increase of 302 and 504 respectively over the previous year. The third-tier public hospitals and second-tier public hospitals carried out 6,086,000 person-times and 3.681 million person-times in remote medical services.
It is worth mentioning that Fu Wei, director of the Health Development Research Center of the China National Health Commission, said that in this new crown epidemic prevention and control, the Medical Federation is under unified and efficient organizational leadership, division of labor between the upper and lower institutions, and the integration of materials and resources The use, as well as the sharing of information and data, have shown advantages.
Take multiple measures and reduce the burden on the public
The report shows that the new medical reform takes the centralized procurement and use of medicines as a breakthrough, and adopts various measures to further reduce the cost of medicines. On the one hand, increase the intensity of centralized drug bidding and procurement to further reduce drug prices. On the other hand, strengthen the management of medicines in medical institutions, strengthen the monitoring of rational medicines, promote the priority of medical institutions to use national essential medicines, promote the reduction of medicine costs, and make room for further adjustment of medical service prices.
According to Liang Wannian, the official is committed to promoting the centralized procurement and use of drugs organized by the state, focusing on reducing the high price of false drugs. The average price of the first 25 selected drugs has been reduced by 52%. In September 2019, the pilot expanded the scope of the region and promoted centralized volume procurement throughout the country. Mode, and focus on the implementation of the results of the negotiations on the access to medical insurance for anticancer drugs. The medical insurance for 17 anticancer drugs has been reimbursed 960,000 times, with a reimbursement amount of 5.2 billion yuan (RMB, the same below).
In addition, the report points out that China has basically established a basic medical security system that covers the entire population, and has achieved a change in the scope of coverage from some groups to all groups, from a single system to multiple levels of protection. Improve steadily.
At the same time, commercial health insurance companies are also developing supplementary insurance, including nursing care insurance, disability income loss insurance, and medical accident insurance, to meet people's diverse, multi-level, and personalized health protection needs. From January to October 2019, the premium income of commercial health insurance reached 614.1 billion yuan, an increase of 30.7% year-on-year; the payment of compensation was 183.8 billion yuan, an increase of 37.28% year-on-year.
New contradictions need further reform
From the original "lack of doctors and medicines" to the current "with medicines and medicines", to the pursuit of "excellent medicines and medicines", people's desire and demand for health are gradually increasing. Wu Peixin, secretary of the Party Committee of the Chinese Academy of Medical Sciences, said that health care There is a contradiction between the people's demand for high-quality and efficient medical and health services and the uneven and inadequate development of medical and health services in the field. It is necessary to further deepen the reform of the medical and health system.
To this end, the report looks forward to the main problems that the medical reform will face in the next step, and gives suggestions on the pain points and difficulties of the reform of public hospitals and the improvement of the drug supply guarantee system.
In his speech, Wang Chen, vice president of the Chinese Academy of Engineering and dean of the Chinese Academy of Medical Sciences, provided ideas for the next step of medical reform from the perspective of industry development. He believes that the professionalism of the medical industry is very prominent, and medical education and medical research must keep up. Only by embodying the professionalism of the employees in science, technology and culture can we win the respect of the society and make the industry develop better. (Finish)